Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 2 2Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 13Other hematologic neoplasm 12Plasma cell 7Dermatologic 6Myeloid 5Genitourinary 4Breast 4Head & Neck 3Thoracic 2Sarcoma 2Gynecologic 1Gastrointestinal 1Classical hematology 1CNS 1

Conditions

Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Neoplasm Metastasis 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Carboplatin 547Pemetrexed 402Cisplatin 400Paclitaxel 272Docetaxel 255Gemcitabine 218pembrolizumab 190Bevacizumab 190Erlotinib Hydrochloride 184Radiotherapy 179Etoposide 147durvalumab 140Nivolumab 134Drug Therapy 127osimertinib 106atezolizumab 92Gefitinib 74Radiosurgery 71anlotinib 69Vinorelbine 68tislelizumab 52Irinotecan 51Ipilimumab 50130-nm albumin-bound paclitaxel 49Taxes 48Surgical Procedures, Operative 46Cetuximab 46sintilimab 45Albumin-Bound Paclitaxel 45apatinib 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Flow Cytometry × Thoracic × Clear all
NCT00514215 2020-03-05

Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer

Barbara Ann Karmanos Cancer Institute

Phase 2 Completed
8 enrolled 5 charts
GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Neoplasm Metastasis

NCT00041028 2015-05-01

EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Completed
60 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡